SCHEMBL14410

SCHEMBL14410

NC(=O)c1ccc(-n2cc3cc(-c4ccc(S(=O)(=O)N(CCOc5ccc(F)cc5)C5CCNCC5)cc4)[nH]c3nc2=O)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 2/20 0.37
AVPR1B P47901 1/20 0.36
MAPK14 Q16539 1/20 0.35
KIT P10721 5/20 0.33
SCN9A Q15858 2/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RAB9A P51151 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KCNH2 Q12809 1/20 0.32
RIPK1 Q13546 1/20 0.32
APOBEC3A P31941 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14299 0.84 KIT (0.35) KITSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL13941 0.80 SLC6A4 (0.36) AVPR1BKITALDH1A1HDAC3HDAC8
SCHEMBL12062122 0.75 KIT (0.36) KITSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL14356 0.75 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3KCNH2PSEN1
SCHEMBL12061894 0.74 SLC6A2 (0.36) AVPR1BSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL14362 0.74 SLC6A2 (0.35) KITSLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL12061513 0.74 SLC6A2 (0.32) SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL12062020 0.73 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3KCNH2PSEN1
SCHEMBL14453 0.73 SLC6A2 (0.38) AVPR1BKITADORA2AADORA2BALDH1A1
SCHEMBL14352 0.73 SLC6A2 (0.35) ADORA2BSLC6A2SLC6A4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488525-B1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MELINTA THERAPEUTICS INC (US) 2018-04-25 EP disclosed
US-20160031893-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME BioVersys AG (CH) 2016-02-04 US disclosed
US-9193731-B2 Antimicrobial compounds and methods of making and using the same MELINTA THERAPEUTICS, INC. (US) 2015-11-24 US disclosed
US-9193731-B2 Antimicrobial compounds and methods of making and using the same MELINTA THERAPEUTICS, INC. (US) 2015-11-24 US disclosed
US-20120220566-A1 Antimicrobial Compounds and Methods of Making and Using the Same RIB-X PHARMACEUTICALS, INC. (US) 2012-08-30 US disclosed
US-20120220566-A1 Antimicrobial Compounds and Methods of Making and Using the Same RIB-X PHARMACEUTICALS, INC. (US) 2012-08-30 US disclosed
WO-2011047319-A2 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220566-A1 Antimicrobial Compounds and Methods of Making and Using the Same MPO, LPO, CAT CHEK2 4573/4885AVPR1B 3493/4885MAPK14 3714/4885
US-20160031893-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MPO, LPO, CAT CHEK2 4573/4885AVPR1B 3493/4885MAPK14 3714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.